Modulation of HDL metabolism by the niacin receptor GPR109A in mouse hepatocytes.

Biochemical Pharmacology
Xiaoyu LiDaniel J Rader

Abstract

The niacin receptor GPR109A is a G(i)-protein-coupled receptor which mediates the effects of niacin on inhibiting intracellular triglyceride lipolysis in adipocytes. However, the role of GPR109A in mediating the effects of niacin on high density lipoprotein (HDL) metabolism is unclear. We found niacin has no effect on HDL-C in GPR109A knockout mice. Furthermore, niacin lowered intracellular cAMP in primary hepatocytes mediated by GPR109A. We used an adeno-associated viral (AAV) serotype 8 vector encoding GPR109A under the control of the hepatic-specific thyroxine-binding globulin promoter to specifically overexpress GPR109A in mouse liver. Plasma HDL-C, hepatic ABCA1 and the HDL cholesterol production rate were significantly reduced in mice overexpressing GPR109A. Overexpression of GPR109A reduced primary hepatocyte free cholesterol efflux to apoA-I; conversely, GPR109A deficient hepatocytes had increased ABCA1-mediated cholesterol efflux. These data support the concept that the HDL-C lowering effect of niacin in wild-type mice is mediated through stimulation of GPR109A in hepatocytes; such an effect then leads to reduced hepatocyte ABCA1 expression and activity, decreased cholesterol efflux to nascent apoA-I, and reduced HDL-C...Continue Reading

References

Nov 9, 1989·The New England Journal of Medicine·D J Gordon, B M Rifkind
Dec 1, 1988·European Journal of Clinical Investigation·L L BaussermanP N Herbert
Jan 1, 1997·Arteriosclerosis, Thrombosis, and Vascular Biology·U GoldbourtJ H Medalie
Jul 22, 1998·Proceedings of the National Academy of Sciences of the United States of America·A HerrlichT Gudermann
Feb 21, 2002·The Journal of Biological Chemistry·Kamran SalimPaul C Guest
Nov 28, 2002·Journal of Lipid Research·Bassam HaidarJacques Genest
Jan 11, 2003·The Journal of Biological Chemistry·Alan WiseNicholas B Pike
Feb 4, 2003·Nature Medicine·Sorin TunaruStefan Offermanns
Mar 21, 2003·Biochemical and Biophysical Research Communications·Takatoshi SogaKiyoshi Furuichi
Nov 3, 2004·Journal of Lipid Research·Maki TsujitaShinji Yokoyama
Jun 3, 2005·The Journal of Biological Chemistry·Andrew K P TaggartM Gerard Waters
Jun 21, 2005·Journal of Cardiovascular Pharmacology·Vanessa DeclercqMohammed H Moghadasian
Jul 16, 2005·Journal of Internal Medicine·L A Carlson
Jul 16, 2005·Biochemical and Biophysical Research Communications·Youyan ZhangGuoqing Cao
Dec 3, 2005·The Journal of Clinical Investigation·Zoltán BenyóStefan Offermanns
Nov 25, 2006·Molecular and Cellular Biochemistry·Lubing ZhouKeith T Demarest
Mar 6, 2007·Biochemical and Biophysical Research Communications·Melba HernandezTian-Quan Cai
May 4, 2007·Cardiovascular Diabetology·Corinna LebherzDaniel J Rader
Oct 13, 2007·Cell Death and Differentiation·G KostylinaH U Simon
Nov 16, 2007·Fundamental & Clinical Pharmacology·Heinz Drexel
Nov 27, 2007·British Journal of Pharmacology·E T Bodor, S Offermanns
Dec 22, 2007·Malaria Journal·Lígia A GonçalvesCarlos Penha-Gonçalves
Jun 21, 2008·Arteriosclerosis, Thrombosis, and Vascular Biology·Stefania Lamon-FavaErnst J Schaefer
Aug 2, 2008·Arteriosclerosis, Thrombosis, and Vascular Biology·José W A van der HoornHans M G Princen
Feb 25, 2009·Proceedings of the National Academy of Sciences of the United States of America·Yoko Irukayama-TomobeTakeshi Sakurai
Apr 8, 2009·The Journal of Clinical Investigation·Robert W WaltersRobert J Lefkowitz
Oct 20, 2009·Trends in Pharmacological Sciences·Kashan AhmedStefan Offermanns

❮ Previous
Next ❯

Citations

Jul 14, 2012·Nature Reviews. Drug Discovery·Clara C BladStefan Offermanns
Feb 22, 2012·Cold Spring Harbor Symposia on Quantitative Biology·C Cantó, J Auwerx
Mar 23, 2011·Diabetes, Obesity & Metabolism·D Wanders, R L Judd
Aug 30, 2012·Journal of Lipid Research·Indumathi ChennamsettyGerhard M Kostner
Jan 17, 2016·Metabolism: Clinical and Experimental·Emily C GraffRobert L Judd
Jul 15, 2015·Domestic Animal Endocrinology·E C GraffR L Judd
May 20, 2015·International Journal of Pharmaceutics·Dustin L CooperSam Harirforoosh
Sep 29, 2011·Journal of Dairy Science·E C TitgemeyerB J Bradford
Nov 2, 2016·Asian-Australasian Journal of Animal Sciences·Lei LiuFuchang Li
Apr 6, 2017·Cell Metabolism·Anna Sofie HustedThue W Schwartz
May 2, 2017·Human Molecular Genetics·Genki HayashiGino Cortopassi
Jun 29, 2017·Immunological Reviews·Craig McKenzieCharles R Mackay
Jul 9, 2011·Circulation Research·Scott M DeWire, Jonathan D Violin
Jan 1, 2015·Immune Network·Chang H KimMyunghoo Kim
Jan 1, 2019·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Lingyan YeNaiming Zhou
Oct 10, 2019·Aging·Ravirajsinh N Jadeja, Pamela M Martin
May 9, 2019·Scientific Reports·Éva SzentirmaiLevente Kapás
May 13, 2019·Journal of Biomedical Science·Keisuke OkabeTakashi Nakagawa
Mar 16, 2021·World Journal of Gastroenterology : WJG·Ming Yang, Chun-Ye Zhang
May 1, 2021·International Journal of Molecular Sciences·Caroline E GeislerBenjamin J Renquist

❮ Previous
Next ❯

Related Concepts

Related Feeds

ApoE, Lipids & Cholesterol

Serum cholesterol, triglycerides, apolipoprotein B (APOB)-containing lipoproteins (very low-density lipoprotein (VLDL), immediate-density lipoprotein (IDL), and low-density lipoprotein (LDL), lipoprotein A (LPA)) and the total cholesterol/high-density lipoprotein (HDL) cholesterol ratio are all connected in diseases. Here is the latest research.